J W N Akkerman

1.5k total citations
48 papers, 1.3k citations indexed

About

J W N Akkerman is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J W N Akkerman has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 14 papers in Molecular Biology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J W N Akkerman's work include Platelet Disorders and Treatments (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Blood properties and coagulation (10 papers). J W N Akkerman is often cited by papers focused on Platelet Disorders and Treatments (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Blood properties and coagulation (10 papers). J W N Akkerman collaborates with scholars based in Netherlands, United States and Germany. J W N Akkerman's co-authors include Gijsbert van Willigen, Gertie Gorter, Adrie J.M. Verhoeven, E.D. Sprengers, Holm Holmsen, C. M. Hackeng, Ingrid A.M. Relou, Arnold C. Koekman, Ernst Malle and Winfried Siffert and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

J W N Akkerman

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J W N Akkerman Netherlands 24 478 363 291 194 171 48 1.3k
Gertie Gorter Netherlands 23 437 0.9× 412 1.1× 415 1.4× 283 1.5× 140 0.8× 51 1.3k
L B Safier United States 15 519 1.1× 301 0.8× 428 1.5× 216 1.1× 222 1.3× 25 1.7k
Lenore B. Safier United States 10 290 0.6× 307 0.8× 241 0.8× 165 0.9× 136 0.8× 12 1.2k
J P Le Couedic France 15 516 1.1× 446 1.2× 208 0.7× 106 0.5× 124 0.7× 22 1.6k
H. Patscheke Germany 18 515 1.1× 196 0.5× 271 0.9× 107 0.6× 168 1.0× 57 1.2k
K. Satoh Japan 18 180 0.4× 365 1.0× 206 0.7× 215 1.1× 90 0.5× 33 1.3k
A J Marcus United States 7 230 0.5× 206 0.6× 296 1.0× 137 0.7× 106 0.6× 10 1.0k
Concetta Di Febbo Italy 18 155 0.3× 215 0.6× 255 0.9× 184 0.9× 84 0.5× 31 1.0k
L. Lenti Italy 20 172 0.4× 291 0.8× 134 0.5× 189 1.0× 63 0.4× 47 1.2k
Paul C. Armstrong United Kingdom 23 369 0.8× 234 0.6× 543 1.9× 219 1.1× 149 0.9× 50 1.4k

Countries citing papers authored by J W N Akkerman

Since Specialization
Citations

This map shows the geographic impact of J W N Akkerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J W N Akkerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J W N Akkerman more than expected).

Fields of papers citing papers by J W N Akkerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J W N Akkerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J W N Akkerman. The network helps show where J W N Akkerman may publish in the future.

Co-authorship network of co-authors of J W N Akkerman

This figure shows the co-authorship network connecting the top 25 collaborators of J W N Akkerman. A scholar is included among the top collaborators of J W N Akkerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J W N Akkerman. J W N Akkerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerrits, Anja J., Eelo Gitz, Arnold C. Koekman, et al.. (2012). Induction of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1 and retinol binding protein 4 in human megakaryocytes. Haematologica. 97(8). 1149–1157. 36 indexed citations
2.
Gitz, Eelo, Arnold C. Koekman, D.J. van den Heuvel, et al.. (2012). Improved platelet survival after cold storage by prevention of glycoprotein Ib  clustering in lipid rafts. Haematologica. 97(12). 1873–1881. 33 indexed citations
3.
Gerrits, Anja J., et al.. (2008). Insulin inhibits tissue factor expression in monocytes. Journal of Thrombosis and Haemostasis. 7(1). 198–205. 30 indexed citations
4.
Relou, Ingrid A.M., C. M. Hackeng, J W N Akkerman, & Ernst Malle. (2003). Low-density lipoprotein and its effect on human blood platelets. Cellular and Molecular Life Sciences. 60(5). 961–971. 71 indexed citations
5.
Relou, Ingrid A.M., C. M. Hackeng, Gertie Gorter, et al.. (2000). Early platelet activation by low density lipoprotein. Atherosclerosis. 151(1). 299–299. 1 indexed citations
6.
Nieuwland, Rienk, Gijsbert van Willigen, & J W N Akkerman. (1993). 4,4′-Di-isothiocyanatostilbene-2,2′-disulphonic acid (‘DIDS’) activates protein kinase C and Na+/H+ exchange in human platelets via α2A-adrenergic receptors. Biochemical Journal. 293(2). 523–530. 4 indexed citations
7.
Rosskopf, Dieter, G Siffert, Klaus K. Witte, et al.. (1992). Platelet Na(+)-H+ exchanger activity in normotensive and hypertensive subjects: effect of enalapril therapy upon antiport activity.. PubMed. 10(8). 839–47. 48 indexed citations
8.
Prooijen, H. C. van, et al.. (1989). Differences in the susceptibility of platelets to freezing damage in relation to size. Transfusion. 29(6). 539–543. 4 indexed citations
10.
Akkerman, J W N, et al.. (1987). The Influence of Cyclandelate on Ca++ Translocation in Human Platelets. Drugs. 33(Supplement 2). 53–59. 4 indexed citations
11.
Sprengers, E.D., et al.. (1986). Blood Platelet Plasminogen Activator Inhibitor: Two Different Pools of Endothelial Cell Type Plasminogen Activator Inhibitor in Human Blood. Thrombosis and Haemostasis. 55(3). 325–329. 84 indexed citations
12.
Verhoeven, Adrie J.M., et al.. (1985). Balanced contribution of glycolytic and adenylate pool in supply of metabolic energy in platelets.. Journal of Biological Chemistry. 260(5). 2621–2624. 16 indexed citations
14.
Haas, Gerard H. De, et al.. (1983). Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. Thrombosis Research. 29(6). 595–608. 24 indexed citations
15.
Akkerman, J W N. (1978). Regulation of Carbohydrate Metabolism in Platelets. Thrombosis and Haemostasis. 39(3). 712–724. 47 indexed citations
16.
Akkerman, J W N, Gertie Gorter, S. de Graaf, et al.. (1978). Evaluation of Platelet Tests for Measurement of Cell Integrity. Thrombosis and Haemostasis. 39(1). 146–157. 20 indexed citations
17.
Slots, J, A. S. J. P. A. M. van Miert, J W N Akkerman, & A.L.W. de Gee. (1977). Trypanosoma brucei and Trypanosoma vivax: Antigen-antibody complexes as a cause of platelet serotonin release in vitro and in vivo. Experimental Parasitology. 43(1). 211–219. 6 indexed citations
18.
Akkerman, J W N, et al.. (1977). The Hermansky‐Pudlak Syndrome. Scandinavian Journal of Haematology. 18(3). 249–256. 24 indexed citations
19.
Heukelom, Matthijs L. Siegenbeek van, J W N Akkerman, G.E.J. Staal, et al.. (1977). A patient with purine nucleoside phosphorylase deficiency: Enzymological and metabolic aspects. Clinica Chimica Acta. 74(3). 271–279. 25 indexed citations
20.
Akkerman, J W N, et al.. (1977). Heparin Pharmacokinetics. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026